论文部分内容阅读
目的对比观察利多卡因、胺碘酮治疗急性心肌梗死合并室早和或室速的短期临床疗效。方法对72例急性心肌梗死合并发生室早和或室速的病人随机分成两组,每组各36例,分别给与利多卡因(观察组)和胺碘酮(对照组)微泵静脉注入,观察各自的疗效,并对结果进行回顾性分析。结果72例急性心肌梗死合并室早和或室速患者使用利多卡因组有效率94.4%,治愈率88.9%,胺碘酮组有效率80.6%,治愈率70.0%,观察组的有效率和治愈率明显高于对照组,二者存在显著性差异(P<0.05)。结论急性心肌梗死患者发生室早和或室速时药物治疗可选利多卡因。
Objective To compare the short-term clinical efficacy of lidocaine and amiodarone in the treatment of acute and early myocardial infarction with ventricular tachycardia or ventricular tachycardia. Methods 72 patients with acute myocardial infarction complicated by ventricular premature ventricular rate or ventricular tachycardia were randomly divided into two groups (n = 36 each), which were given intravenous injection of lidocaine (observation group) and amiodarone , Observe their respective curative effect, and retrospectively analyze the result. Results 72 cases of acute myocardial infarction with ventricular tachycardia or ventricular tachycardia in patients with lidocaine group was 94.4%, the cure rate was 88.9%, amiodarone group 80.6%, the cure rate was 70.0%, the observation group, the effective rate and cure Rate was significantly higher than the control group, there was a significant difference between the two (P <0.05). Conclusion Patients with acute myocardial infarction may have premature ventricular or ventricular tachycardia treatment with optional lidocaine.